Market revenue in 2023 | USD 61.6 million |
Market revenue in 2030 | USD 86.1 million |
Growth rate | 4.9% (CAGR from 2023 to 2030) |
Largest segment | Percutaneous thrombectomy devices |
Fastest growing segment | Neurovascular Embolectomy Devices |
Historical data | 2018 - 2022 |
Base year | 2023 |
Forecast period | 2024 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Neurovascular Embolectomy Devices, Embolectomy Balloon Catheters, Percutaneous Thrombectomy Devices, Catheter-directed thrombolysis (CDT) devices, Inferior vena cava filters (IVCF) |
Key market players worldwide | Medtronic PLC, Boston Scientific Corp, Teleflex Inc, Edwards Lifesciences Corp, LeMaitre Vascular Inc, Cook Medical, DePuy Synthes, iVascular, Vascular Solutions |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to clot management devices market will help companies and investors design strategic landscapes.
Percutaneous thrombectomy devices was the largest segment with a revenue share of 36.2% in 2023. Horizon Databook has segmented the Japan clot management devices market based on neurovascular embolectomy devices, embolectomy balloon catheters, percutaneous thrombectomy devices, catheter-directed thrombolysis (cdt) devices, inferior vena cava filters (ivcf) covering the revenue growth of each sub-segment from 2018 to 2030.
According to the Japanese Society of Hypertension, high blood pressure affects 2 out of 10 people in the country. Moreover, only 50% of these patients are treated actively to control their blood pressure. Thus, a large population of untreated blood pressure patients is expected to continue to drive the market for clot management devices.
Moreover, as per healtdata.org, it was estimated that stroke is the second leading cause of death in Japan, and mortality due to stroke increased by 15.8% between 2009 and 2019. Moreover, healthcare spending in Japan is expected to grow by 43.34% by 2050. Thus, growing healthcare spending is expected to drive Japan’s clot management market growth over the forecast period.
Horizon Databook provides a detailed overview of country-level data and insights on the Japan clot management devices market , including forecasts for subscribers. This country databook contains high-level insights into Japan clot management devices market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account